Human chromosome 7 has been the focus of many behavioral, genetic, and medical studies because it carries genes related to cancer and neurodevelopment. We examined the evolution of the chromosome 7 homologs, and the 7q31 region in particular, using chromosome painting analyses and 3 paint probes derived from (i) the whole of chimpanzee chromosome VII (wcVII), (ii) human 7q31 (h7q31), and (iii) the chimpanzee homolog VIIq31 (cVIIq31). The wcVII probe was used instead of the whole human chromosome 7 because the chimpanzee contains additional C-bands and revealed large areas of synteny conservation as well as fragmentation across 20 primate species. Analyses focusing specifically on the 7q31 homolog and vicinity revealed considerable conservation across lineages with 2 exceptions. First, the probes verified an insertion of repetitive sequence at VIIq22 in chimpanzees and bonobos and also detected the sequence in most subtelomeres of the African apes. Second, a paracentric inversion with a breakpoint in the cVIIq31 block was found in the common marmoset, confirming earlier studies. Subsequent in silico comparative genome analysis of 17 primate species revealed that VIIq31.1 is more significantly conserved at the sequence level than other regions of chromosome VII, which indicates that its components are likely responsible for critical shared traits across the order, including conditions necessary for proper human development and wellbeing.

Keywords:
Chromosome evolution, Chromosome microdissection, Chromosome paint analysis, Synteny block, Zoo-FISH
1.
Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, et al: Ultraconserved elements in the human genome. Science 304:1321-1325 (2004).
2.
Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, et al: Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339:139-143 (1992).
3.
Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, et al: A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acd Sci USA 103:16834-16839 (2006).
4.
Catacchio CR, Maggiolini FAM, D'Addabbo P, Bitonto M, Capozzi O, et al: Inversion variants in human and primate genomes. Genome Res 28:910-920 (2018).
5.
Champeme MH, Bieche I, Beuzelin M, Lidereau R: Loss of heterozygosity on 7q31 occurs early during breast tumorigenesis. Genes Chromosomes Cancer 12:304-306 (1995).
6.
Charong N, Patmasiriwat P, Zenklusen JC: Localization and characterization of ST7 in cancer. J Cancer Res Clin Oncol 137:89-97 (2011).
7.
Christian AT, Garcia HE, Tucher JD: PCR in situ followed by microdissection allows whole chromosome painting probes to be made from single microdissected chromosomes. Mamm Genome 10:628-631 (1999).
8.
Dumas F, Stanyon R, Sineo L, Stone G, Bigoni F: Phylogenomics of species from four genera of New World monkeys by flow sorting and reciprocal chromosome painting. BMC Evol Biol 7:S11 (2007).
9.
Enard W, Przeworski M, Fisher SE, Lai CSL, Wiebe Y, et al: Molecular evolution of FOXP2, a gene involved in speech and language. Nature 418: 869-872 (2002).
10.
Fisher SM: On gene, speech, and language. N Engl J Med 353:1655-1657 (2005).
11.
Glukhova L, Lavialle C, Fauvet D, Chudoba I, Danglot G, et al: Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene. Oncogene 19:754-761 (2000).
12.
Grabellus F, Konik M, Worm K, Sheu S-Y, van de Nes JAP, et al: MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions. Tumour Biol 31:57-163 (2010).
13.
Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, et al: The DNA sequence of human chromosome 7. Nature 424:157-164 (2003).
14.
Hirai H, Taguchi T, Godwin AK: Genomic differentiation of 18S ribosomal DNA and β-satellite DNA in the hominoid and its evolutionary aspects. Chromosome Res 7:531-540 (1999).
15.
Hirai H, Hirai Y, Kawamoto Y, Endo H, Kimura J, Rerkamnuaychoke W: Cytogenetic differentiation of two sympatric tree shrew taxa found in the southern part of the Isthmus of Kra. Chromosome Res 10:313-327 (2002).
16.
Hirai H, Matsubayashi K, Kumazaki K, Kato A, Maeda N, Kim H-S: Chimpanzee chromosomes: retrotransposable compound repeat DNA organization (RCRO) and its influence on meiotic prophase and crossing-over. Cytogenet Genome Res 108:248-254 (2005a).
17.
Hirai H, Wijayanto H, Tanaka H, Mootnick AR, Hayano A, et al: A whole-arm translocation (WAT8/9) separating Sumatran and Bornean agile gibbons, and its evolutionary features. Chromosome Res 13:123-133 (2005b).
18.
Hirai H, Hirai Y, LoVerde PT: Evolution of sex chromosomes ZW of Schistosoma mansoni inferred from chromosome paint and BAC mapping analyses. Parasitol Int 61:684-689 (2012).
19.
Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, et al: A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 58:759-766 (1998).
20.
Koga A, Notohara M, Hirai H: Evolution of subterminal satellite (StSat) repeats in hominids. Genetica 139:167-175 (2011).
21.
Larkin DM, Page G, Donthu R, Auvil L, Welge M, Lewin HA: Breakpoint regions and homologous synteny blocks in chromosomes have different evolutionary histories. Genome Res 19:770-777 (2009).
22.
Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscot JS: Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol 93:75-80 (1996).
23.
Liang H, Fairman J, Claxton DF, Nowell PC, Green ED, Nagarajan L: Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA 95:3781-3785 (1998).
24.
Morgan A, Fisher SE, Scheffer I, Hildebrand M: FOXP2-related speech and language disorders, in Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, et al (eds): GeneReviews [Internet] (University of Washington, Seattle 2017).
25.
Müller S, Hollatz M, Wienberg J: Chromosomal phylogeny and evolution of gibbons (Hylobatidae). Hum Genet 113:493-501 (2003).
26.
Müller S, Finelli P, Neusser M, Wienberg J: The evolutionary history of human chromosome 7. Genomics 84:458-467 (2004).
27.
Murphy WJ, Larkin DM, Everts-van der Wind A, Bourque G, Tesler G, et al: Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps. Science 309:613-617 (2005).
28.
Nie W: Molecular cytogenetic studies in Strepsisshine primates, Dermoptera and Scandentia. Cytogenet Genome Res 137:246-258 (2012).
29.
Nishizaka S, Tamura G, Terashima M, Saodate R: Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach. Br J Cancer 76:1567-1571 (1997).
30.
Park M, Testa JR, Blair DG, Parsa NZ, Vande Woude GF: Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus. Pro Natl Acad Sci USA 85:2667-2671 (1988).
31.
Prat E, Bernues M, Del Rey J Camps J, Ponsa I, et al: Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma. Cancer Genet Cytogenet 164:142-147 (2006).
32.
Richard F, Lombard M, Dutrillaux B: Phylogenetic origin of human chromosome 7, 16, and 19 and their homologs in placental mammals. Genome Res 10:644-651 (2000).
33.
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073 (1989).
34.
Royle NJ, Baird DM, Jeffreys AJ: A subterminal satellite located adjacent to telomeres in chimpanzees is absent from the human genome. Nat Genet 6:52-56 (1994).
35.
Scherthan H, Cremer T, Arnason U, Weier HU, Lima-de-Faria A, Fronicke L: Comparative chromosome painting discloses homologous segments in distantly related mammals. Nat Genet 6:342-347 (1994).
36.
Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou U, et al: Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15:1034-50 (2005).
37.
Stanyon R, Bigoni F, Slaby T, Müller S, Stone G, et al: Multi-directional chromosome painting maps homologies between species belonging to three genera of New World monkeys and human. Chromosoma 113:305-315 (2004).
38.
Stanyon R, Rocchi M, Capozzi O, Robert R, Misceo D, et al: Primate chromosome evolution: ancestral karyotypes, marker order and neocentromeres. Chromosome Res 16:17-39 (2008).
39.
Tam CS, Abruzzo LV, Lin KI Cortes J, Lynn A, et al: The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course. Blood 113:4171-4178 (2009).
40.
Ventura M, Catacchio C, Sajjadian S, Vives L, Sudmant P, et al: The evolution of African great ape subtelomeric heterochromatin and the fusion of human chromosome 2. Genome Res 22:1036-1049 (2012).
41.
Warter S, Hauwy M, Dutrillaux B, Rumpler Y: Application of molecular cytogenetics for chromosomal evolution of the Lemuriformes (Prosimians). Cytogenetic Genome Res 108:197-203 (2005).
42.
Weinberg J: Fluorescence in situ hybridization to chromosomes as a tool to understand human and primate genome evolution. Cytogenet Genome Res 108:139-160 (2005).
43.
Yunis JJ, Prakash O: The origin of man: a chromosomal pictorial legacy. Science 215:1525-1530 (1982).
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.